Pharmacoeconomic Analysis of Liposomal Amphotericin B versus Voriconazole for Empirical Treatment of Febrile Neutropenia

Author： Collins Curtis D.   Stuntebeck Emily R.   DePestel Daryl D.   Stevenson James G.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.4, 2007-01, pp. : 233-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D.   Lyseng-Williamson Katherine A.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

By Kuti J.L.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 301-310

Adis International

Access to resources Recommend Favorite

Voriconazole: appropriate empirical therapy in febrile neutropenia?

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Liposomal amphotericin B as a treatment for human leishmaniasis

By Balasegaram Manica  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 493-510

Informa Healthcare

Access to resources Recommend Favorite

Caspofungin: Breakthrough Candida spp. encephalitis in an elderly patient, treated with voriconazole and amphotericin B liposomal: case report

By  

Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite